Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10822585
Compositions and methods for treating retinal diseases
granted -
US 10822427
Anti-CSPG4 fusions with interferon for the treatment of malignancy
granted -
US 10822353
Dithio ETP derivatives
granted -
US 10822299
Compounds and methods for hematopoietic regeneration
granted -
US 10813894
Methods of inhibiting pain
granted -
US 10815271
Structure-based peptide inhibitors of alpha-synuclein aggregation
granted -
US 10813909
Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer
granted -
US 10806807
TCO conjugates and methods for delivery of therapeutic agents
granted -
US 10807951
mTORC1 modulators
granted -
US 10806702
Bis-polymer lipid-peptide conjugates and nanoparticles thereof
granted -
US 10799512
Estrogen combination for treatment of multiple sclerosis
granted -
US 10800749
Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them
granted -
US 10800797
Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
granted -
US 10801030
General secretory pathway (GSP) mutant listeria SPP., and methods for making and using the same
granted -
US 10792287
Methods for treating mitochondrial diseases
granted -
US 10793884
Methods and materials for making simvastatin and related compounds
granted -
US 10793846
Compositions and methods for treating celiac sprue disease
granted -
US 10793878
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10786495
Vesicular monoamine transporter 2 inhibitors for treating stuttering
granted -
US 10780133
Method for protecting liver and a liver protecting agent
granted -
US 10780078
Mu opioid receptor modulators
granted -
US 10780136
Reduction of milk glycans and their degradation products in the neonate gut
granted -
US 10780131
Ameliorating nervous systems disorders
granted -
US 10781422
Compositions and methods for treating retinal diseases
granted